Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity.

We conclude that while NA treatment has no effect on operation complexity, peri-OP mortality or post-OP morbidity; its impact on long term survival is protuberant, therefore, we believe that NA treatment should be considered as the treatment of choice in advanced NSCLC in need for pneumonectomy.